Medicare Enrolled
Dr. Steven Pascal, M.D.
Ophthalmology · Oakland, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pascal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pascal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pascal
Dr. Steven Pascal is an ophthalmology specialist in Oakland, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pascal performed 4,147 Medicare services across 3,398 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pascal received a total of $4,341 from 29 pharmaceutical and/or device companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pascal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 24% volume in CA
$4,341 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,147
Medicare services
Top 24% in CA for ophthalmology
3,398
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~218 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
939 | $113 | $198 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
820 | $84 | $141 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
447 | $33 | $92 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
371 | $37 | $102 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
307 | $43 | $129 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
263 | $60 | $162 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
225 | $34 | $102 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
208 | $490 | $2,029 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
187 | $137 | $245 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $52 | $85 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
59 | $316 | $1,380 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
49 | $683 | $2,713 |
| Imaging of front third of eye Imaging of the front third of the eye. |
27 | $28 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $106 | $184 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
23 | $175 | $922 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
22 | $29 | $93 |
| Eye deviation and range of motion exam An examination to measure eye deviation and assess the range of motion of the eyes. |
21 | $60 | $160 |
| Cataract removal with artificial lens and drainage device insertion Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye. |
18 | $626 | $2,471 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
18 | $9 | $29 |
| Dilation of eye fluid drainage A procedure to widen the drainage pathways in the eye to help fluid flow out more easily. |
16 | $317 | $2,352 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $135 | $263 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $75 | $163 |
| New patient office visit, complex (60-74 min) | 13 | $197 | $320 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.0% high complexity
21.3% medium
73.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,341
Total received (2018-2024)
Avg $620/year across 7 years
Top 27% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
207
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,341 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,404
2023
$1,122
2022
$588
2021
$342
2020
$349
2019
$328
2018
$207
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$367
Alcon Vision LLC
$306
NEW WORLD MEDICAL,INC.
$169
Tarsus Pharmaceuticals, Inc.
$112
Oyster Point Pharma, Inc.
$106
Sight Sciences, Inc.
$68
SUN PHARMACEUTICAL INDUSTRIES INC.
$54
Glaukos Corporation
$49
Bausch & Lomb Americas Inc.
$39
Thea Pharma Inc.
$38
Amgen Inc.
$34
Harrow Eye, LLC
$24
Johnson & Johnson Surgical Vision, Inc.
$23
Mallinckrodt Hospital Products Inc.
$16
Top 3 companies account for 60.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$812
Alcon Vision LLC
$620
Novartis Pharmaceuticals Corporation
$360
Oyster Point Pharma, Inc.
$347
Bausch & Lomb Americas Inc.
$207
Sun Pharmaceutical Industries Inc.
$195
Sight Sciences, Inc.
$192
Allergan, Inc.
$184
NEW WORLD MEDICAL,INC.
$169
Bausch & Lomb, a division of Bausch Health US, LLC
$163
Johnson & Johnson Surgical Vision, Inc.
$115
Tarsus Pharmaceuticals, Inc.
$112
SUN PHARMACEUTICAL INDUSTRIES INC.
$95
Mallinckrodt Hospital Products Inc.
$88
Glaukos Corporation
$79
Aerie Pharmaceuticals, Inc.
$72
Carl Zeiss Meditec USA, Inc.
$66
GLAUKOS CORPORATION
$63
OPTOS, INC.
$52
Omeros Corporation
$49
Alcon Laboratories Inc
$49
Carl Zeiss Meditec AG
$39
Thea Pharma Inc.
$38
Allergan Inc.
$36
Ivantis, Inc
$36
Amgen Inc.
$34
Harrow Eye, LLC
$24
Akorn, Inc.
$24
Kala Pharmaceuticals, Inc.
$23
Top 3 companies account for 41.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · CEQUA · CIRRUS HD-OCT · Cequa · Clareon · DUREZOL · DURYSTA · HYDRUS Microstent · Hydrus · INVELTYS · ISTENT INJECT W · IYUZEH · Kahook Dual Blade · LOTEMAX SM · LUMIGAN · MIEBO · None Specified · OMNI · OMNI SURGICAL SYSTEM · OMNI Surgical System · OMNI(R) SURGICAL SYSTEM (US) · Omidria · P200DTx · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · RYZUMVI · ReSTOR · Rhopressa · Rocklatan · SIMBRINZA · Simbrinza · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis IOL · Tecnis Simplicity · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · Zioptan · enVista MX60 IOL · iStent Inject Trabecular Micro-Bypass System · iStent Trabecular Micro-Bypass System Model iS3 · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Ophthalmologists within 10 mi
376
Per 100K population
22.8
County median income
$126,240
Nearest hospital
ALTA BATES SUMMIT MEDICAL CENTER
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pascal is a mixed practice specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pascal experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Pascal performed 939 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pascal receive payments from pharmaceutical companies?
Yes. Dr. Pascal received a total of $4,341 from 29 companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pascal's costs compare to other ophthalmologists in Oakland?
Dr. Pascal's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pascal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Oakland
Browse ophthalmologists in Oakland ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in CA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in CA
Which CA ophthalmologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Alcon Vision LLC Payments to Doctors
See all physicians who received payments from Alcon Vision LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology